Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection

Journal of Clinical Virology

Volumn 55, Issue 3, 2012, Pages 233-238

  Kanaan, Nada ^a   Kabamba, Benoit ^a   Maréchal, Céline ^a   Pirson, Yves ^a   Beguin, Claire ^a   Goffin, Eric ^a   Hassoun, Ziad ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

HBsAg negative; HBV; Immunosuppression; Reactivation; Renal; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; ENTECAVIR; GLUCOCORTICOID; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TENOFOVIR; THYMOCYTE ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; VIRUS REACTIVATION;

COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION; VIRUS ACTIVATION;

EID: 84866356153     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.07.015     Document Type: Article

References (38)

1. Mathurin P., Mouquet C., Poynard T., Sylla C., Benalia H., Fretz C., et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999, 29(1):257-263.
2. Fabrizi F., Martin P., Dixit V., Kanwal F., Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005, 5(12):2913-2921.
3. Fornairon S., Pol S., Legendre C., Carnot F., Mamzer-Bruneel M.F., Brechot C., et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996, 62(2):297-299.
4. Tur-Kaspa R., Burk R.D., Shaul Y., Shafritz D.A. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A 1986, 83(6):1627-1631.
5. Tur-Kaspa R., Shaul Y., Moore D.D., Burk R.D., Okret S., Poellinger L., et al. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988, 167(2):630-633.
6. Milich D.R. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 1988, 9(12):380-386.
7. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335-352.
8. Huskey J., Wiseman A.C. Chronic viral hepatitis in kidney transplantation. Nat Rev Nephrol 2011, 7(3):156-165.
9. Lau G.K., Liang R., Chiu E.K., Lee C.K., Lam S.K. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 1997, 19(8):795-799.
10. Duhart B.T., Honaker M.R., Shokouh-Amiri M.H., Riely C.A., Vera S.R., Taylor S.L., et al. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transpl Infect Dis 2003, 5(3):126-131.
11. Knoll A., Pietrzyk M., Loss M., Goetz W.A., Jilg W. Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation. Transplantation 2005, 79(11):1631-1633.
12. Berger A., Preiser W., Kachel H.G., Sturmer M., Doerr H.W. HBV reactivation after kidney transplantation. J Clin Virol 2005, 32(2):162-165.
13. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50(3):661-662.
14. Ong H.T., Duraisamy G., Kee Peng N., Wen Siang T., Seow H.F. Genotyping of hepatitis B virus in Malaysia based on the nucleotide sequence of preS and S genes. Microbes Infect 2005, 7(3):494-500.
15. European Association for the study of the liver EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012, 57(1):167-185.
16. Fong T.L., Di Bisceglie A.M., Gerber M.A., Waggoner J.G., Hoofnagle J.H. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993, 18(6):1313-1318.
17. Mason A., Yoffe B., Noonan C., Mearns M., Campbell C., Kelley A., et al. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992, 16(1):36-41.
18. Loriot M.A., Marcellin P., Bismuth E., Martinot-Peignoux M., Boyer N., Degott C., et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 1992, 15(1):32-36.
19. Marusawa H., Uemoto S., Hijikata M., Ueda Y., Tanaka K., Shimotohmo K., et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000, 31(2):488-495.
20. Raimondo G., Navarra G., Mondello S., Costantino L., Colloredo G., Cucinotta E., et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008, 48(5):743-746.
21. Raimondo G., Pollicino T., Cacciola I., Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007, 46(1):160-170.
22. Vento S., Di Perri G., Luzzati R., Cruciani M., Garofano T., Mengoli C., et al. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet 1989, 333(8633):332-333.
23. Lok A.S., Liang R.H., Chiu E.K., Wong K.L., Chan T.K., Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991, 100(1):182-188.
24. Martin B.A., Rowe J.M., Kouides P.A., DiPersio J.F. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant 1995, 15(1):145-148.
25. Knoll A., Boehm S., Hahn J., Holler E., Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2004, 33(9):925-929.
26. Hoofnagle J.H. Reactivation of hepatitis B. Hepatology 2009, 49(5 Suppl.):S156-S165.
27. Blanpain C., Knoop C., Delforge M.L., Antoine M., Peny M.O., Liesnard C., et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 1998, 66(7):883-886.
28. Romanet P., Vacher-Coponat H., Moal V., Botta-Fridlund D., Motte A., Colson P. Pitfall of hepatitis B surface antigen testing in a kidney transplant recipient presenting hepatitis B reactivation. Clin Res Hepatol Gastroenterol 2011, 35(10):671-674.
29. Waters J., Pignatelli M., Galpin S., Ishihara K., Thomas H.C. Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide. J Gen Virol 1986, 67(Pt 11):2467-2473.
30. Treichel U., Meyer zum Buschenfelde K.H., Stockert R.J., Poralla T., Gerken G. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 1994, 75(Pt 11):3021-3029.
31. Grotz W., Rasenack J., Benzing T., Berthold H., Peter T., Walter E., et al. Occurrence and management of hepatitis B virus reactivation following kidney transplantation. Clin Nephrol 1998, 49(6):385-388.
32. Savas N., Colak T., Yilmaz U., Emiroglu R., Haberal M. Hepatitis B virus reactivation after renal transplantation: report of two cases. Transpl Int 2007, 20(3):301-304.
33. Onozawa M., Hashino S., Izumiyama K., Kahata K., Chuma M., Mori A., et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 2005, 79(5):616-619.
34. Hadler S.C., Francis D.P., Maynard J.E., Thompson S.E., Judson F.N., Echenberg D.F., et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986, 315(4):209-214.
35. Barclay S., Pol S., Mutimer D., Benhamou Y., Mills P.R., Hayes P.C., et al. Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting'. J Clin Virol 2008, 41(4):243-254.
36. KDIGO Clinical Practice Guidelines for the care of kidney transplant recipients. Am J Transpl 2009, 9(Suppl. 3):S53-S57.
37. Davis J.P. Experience with hepatitis A and B vaccines. Am J Med 2005, 118(Suppl. 10A):7S-15S.
38. Poland G.A., Jacobson R.M. Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004, 351:2832-2838.